Can pancreatic cancer cause involvement of Virchow's (left supraclavicular) node?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Research

Yes, pancreatic cancer can cause involvement of Virchow's node (left supraclavicular node). Pancreatic cancer, particularly adenocarcinoma of the pancreas, frequently metastasizes to regional and distant lymph nodes through lymphatic spread. Virchow's node, located in the left supraclavicular region, is a common site for metastasis from abdominal malignancies, including pancreatic cancer. This occurs because the thoracic duct, which drains lymph from much of the abdomen, empties into the venous system near the junction of the left subclavian and internal jugular veins. When pancreatic cancer cells travel through this lymphatic pathway, they can become trapped in the left supraclavicular lymph nodes. Clinically, an enlarged, firm, non-tender Virchow's node (also called Troisier's sign when associated with abdominal malignancy) may be the first detectable sign of pancreatic cancer in some patients. Finding metastasis to Virchow's node typically indicates stage IV disease, which has important implications for treatment planning and prognosis. Any unexplained left supraclavicular lymphadenopathy should prompt consideration of underlying abdominal malignancy, including pancreatic cancer, as noted in studies such as 1 and 2.

Key Points to Consider

  • Pancreatic cancer can metastasize to Virchow's node through lymphatic spread, as discussed in 1.
  • The involvement of Virchow's node is a sign of advanced disease and has significant implications for treatment planning and prognosis, as mentioned in 2.
  • The pattern of lymph node metastasis in pancreatic cancer can be complex and involves both regional and distant lymph nodes, as investigated in 2.
  • Treatment options for pancreatic cancer, including chemotherapy regimens such as FOLFIRINOX and gemcitabine/nab-paclitaxel, are crucial for managing the disease, as discussed in 3 and 4.
  • Recent studies, such as 4, have focused on improving treatment outcomes for patients with metastatic pancreatic adenocarcinoma, highlighting the importance of ongoing research in this area.

Clinical Implications

The involvement of Virchow's node in pancreatic cancer patients is a critical factor in determining the stage and prognosis of the disease. As such, any unexplained left supraclavicular lymphadenopathy should be thoroughly investigated to rule out underlying abdominal malignancy, including pancreatic cancer. This approach is supported by the findings of studies such as 1 and 2, which emphasize the importance of considering pancreatic cancer in the differential diagnosis of patients presenting with Virchow's node involvement.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.